Press release
US Cell & Gene Therapy Market Surges to Reach $25.58 Billion by 2028 - Exclusive Focused Reports by Arizton
US-cell-gene-therapy-market
The US cell and gene therapy market will grow at a compound annual growth rate (CAGR) of 41.25% during 2022-2028.
To Get a Glimpse of our Report, Download the Free Sample Report: https://www.focusreports.store/report/us-cell-gene-therapy-market-focused-insights
The US is the fastest-growing market for cell & gene therapy products globally. The cell & gene therapy market in the US is growing at a healthy rate due to the presence of advanced healthcare infrastructure, high acceptance of cell & gene therapies, and high per capita healthcare expenditure in different states of the US. Based on therapy, the gene therapy segment dominated the US cell & gene therapy market in 2022 with a share of 76.95%. However, this scenario is likely to change as the number of product introductions in gene therapy and better management of the process using advanced vectors will increase the adoption of gene therapy during the forecast period. As a result, the segment will grow to 94.69% in 2028.
Recent Developments
In November 2022, CSL announced that the US FDA approved HEMGENIX (etranacogene dezaparvovec-drlb) for appropriate adults with hemophilia B.
In November 2022, Tenaya Therapeutics received an Orphan Drug Designation from the US Food and Drug Administration for its Gene Therapy for Genetic Arrhythmogenic Right Ventricular Cardiomyopathy.
In November 2022, Sensorion announced that the US FDA granted rare pediatric disease designation to its lead therapy gene candidate, OTOF-GT.
In September 2022, bluebird bio announced the US FDA granted Accelerated Approval of SKYSONA (elivaldogene autotemcel) to slow the progression of neurologic dysfunction in boys of 4-17 years of age with early active cerebral adrenoleukodystrophy (CALD).
The Report Provides Focused Insights Across the Following Sections.
REPORT HIGHLIGHTS
SEGMENTATION & FORECAST
THE FOLLOWING MARKET SEGMENT ANALYSIS IS INCLUDED IN THIS REPORT
Product
Cell Therapy
Gene Therapy
Application
Oncology
Genetic Disorders
Others
End-user
Hospitals
Cancer Care Centers
Others
Competitive Landscape - Gene Therapies
• Key Vendors
• Novartis
• Gilead Sciences
• Amgen
• Roche
• bluebird bio Inc
Other Prominent Vendors
• Bristol-Myers Squibb (BMS)
• Legend Biotech
• UniQure NV
• Ferring Pharmaceuticals
Competitive Landscape - Cell Therapies
Key Vendors
• Organogenesis
• Vericel Corp
• Dendreon
• Mallinckrodt Plc
• Enzyvant
Other Prominent Vendors
• AVITA Medical
• Fibrocell
Key Emerging Investigational Vendors
• 4DMT
• Abeona Therapeutics
• Autolus Therapeutics
• Candel Therapeutics
• Castle Creek Biosciences
• Cellectis
• Evox Therapeutics
• Freeline Therapeutics
• Generation Bio
• GenSight Biologics
• Krystal Biotech
• MeiraGTx
Questions Answered in the Report
What was the value of the U.S. cell and gene therapy market in 2022?
What is the projected value of the U.S. cell and gene therapy market in 2028?
Which type of gene therapy are drug developers prioritizing?
Who are the leading players in the U.S. cell and gene therapy market?
About Focused Reports by Arizton
Welcome to Focused Reports, an esteemed Arizton Advisory & Intelligence subsidiary committed to delivering precise and insightful market research reports across all key geographies. Our unique selling proposition lies in our affordable pricing, accurate data, in-depth research, and presentation-ready reports. With us, expensive market research is a thing of the past. We aim to be strategic, providing valuable data. Focus Reports is where folks come to name their ideas, create a compelling brand and a great-looking website, and attract customers with digital and social marketing.
Contact Us:
Call: +1-312-235-2040
+1 302 469 0707
Mail:enquiry@focusreports.com
Website: https://www.focusreports.store/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Cell & Gene Therapy Market Surges to Reach $25.58 Billion by 2028 - Exclusive Focused Reports by Arizton here
News-ID: 3445380 • Views: …
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
